C
CIDARA THERAPEUTICS INC
NASDAQ: CDTX (Cidara Therapeutics, Inc.)
最近更新时间: 3分钟之前65.62
0.75 (1.16%)
前收盘价格 | 64.87 |
收盘价格 | 64.43 |
成交量 | 377,340 |
平均成交量 (3个月) | 816,304 |
市值 | 1,663,998,592 |
预期市盈率 (P/E Forward) | 5.75 |
价格/销量 (P/S) | 0.990 |
股市价格/股市净资产 (P/B) | 3.21 |
52周波幅 | |
利润日期 | 6 Nov 2025 |
营业利益率 (TTM) | -35,743.71% |
稀释每股收益 (EPS TTM) | -26.68 |
季度收入增长率 (YOY) | -100.00% |
总债务/股东权益 (D/E MRQ) | 1.89% |
流动比率 (MRQ) | 3.87 |
营业现金流 (OCF TTM) | -191.84 M |
杠杆自由现金流 (LFCF TTM) | -81.87 M |
资产报酬率 (ROA TTM) | -55.20% |
股东权益报酬率 (ROE TTM) | -299.58% |
市场趋势
短期 | 中期 | ||
行业 | Biotechnology (US) | 混合的 | 看跌 |
Biotechnology (全球的) | 混合的 | 看跌 | |
股票 | Cidara Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
0.1
分析师共识 | 1.5 |
内部交易活动 | NA |
价格波动 | -4.0 |
技术平均移动指标 | 2.5 |
技术振荡指标 | 0.5 |
平均 | 0.13 |
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company’s portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak® platform targeting oncologic, viral and autoimmune diseases. |
|
部门 | Healthcare |
行业 | Biotechnology |
投资方式 | Small Core |
内部持股比例 | 1.12% |
机构持股比例 | 73.93% |
所有权
姓名 | 日期 | 持有股份 |
---|---|---|
Ra Capital Management, L.P. | 30 Jun 2025 | 3,365,523 |
Bain Capital Life Sciences Investors, Llc | 30 Jun 2025 | 2,500,680 |
Point72 Asset Management, L.P. | 30 Jun 2025 | 1,527,930 |
Vivo Capital, Llc | 30 Jun 2025 | 1,311,425 |
Commodore Capital Lp | 30 Jun 2025 | 1,175,000 |
Blackrock, Inc. | 30 Jun 2025 | 1,107,668 |
Adage Capital Partners Gp, L.L.C. | 30 Jun 2025 | 1,100,000 |
Tcg Crossover Management, Llc | 30 Jun 2025 | 1,005,901 |
Vanguard Group Inc | 30 Jun 2025 | 966,705 |
Morgan Stanley | 30 Jun 2025 | 883,415 |
Bvf Inc/Il | 30 Jun 2025 | 786,392 |
Darwin Global Management, Ltd. | 30 Jun 2025 | 768,424 |
Vr Adviser, Llc | 30 Jun 2025 | 639,088 |
Janus Henderson Group Plc | 30 Jun 2025 | 625,000 |
Vestal Point Capital, Lp | 30 Jun 2025 | 500,000 |
52周波幅 | ||
目标价格波幅 | ||
高 | 75.00 (RBC Capital, 14.29%) | 购买 |
中 | 71.00 (8.20%) | |
低 | 45.00 (WBB Securities, -31.42%) | 购买 |
平均值 | 67.00 (2.10%) | |
总计 | 6 购买 | |
平均价格@调整类型 | 54.11 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
HC Wainwright & Co. | 08 Aug 2025 | 74.00 (12.77%) | 购买 | 62.00 |
24 Jun 2025 | 53.00 (-19.23%) | 购买 | 46.84 | |
JMP Securities | 08 Aug 2025 | 66.00 (0.58%) | 购买 | 62.00 |
30 Jun 2025 | 59.00 (-10.09%) | 购买 | 48.71 | |
Needham | 08 Aug 2025 | 74.00 (12.77%) | 购买 | 62.00 |
23 Jun 2025 | 54.00 (-17.71%) | 购买 | 44.95 | |
Guggenheim | 24 Jun 2025 | 68.00 (3.63%) | 购买 | 46.84 |
RBC Capital | 24 Jun 2025 | 75.00 (14.29%) | 购买 | 46.84 |
WBB Securities | 23 Jun 2025 | 45.00 (-31.42%) | 购买 | 44.95 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合